Cambridge Healthtech Institute’s 8th Annual

CAR Ts, TCRs and TILs

Engineering Strategies to Advance Cellular Immunotherapies

May 12-13, 2021

 

Cambridge Healthtech Institute’s 8th Annual CAR Ts, TCRs and TILs conference focuses on the latest engineering strategies, techniques and tools driving the development of cell-based immunotherapies such as CAR Ts, NK cells, TILs and TCRs for cancer and immune disorders. Topics include novel engineering strategies for solid tumors, allogenic therapy, gene editing, lessons learnt from the clinic, and strategies beyond T cells.

 

Coverage will include, but is not limited to:

 

Engineering strategies in:

 

  • CAR Ts
  • TCRs
  • TILs
  • NK cells
  • Innate immunity
  • Solid tumors
  • Gene-edited cell-based therapy
  • Allogenic cell therapy
  • Safety and resistance

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is November 6, 2020.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Daniel Barry
Senior Conference Director
Cambridge Healthtech Institute
Phone: 44 7837 651 303
Email: dbarry@healthtech.com

For partnering and sponsorship information, please contact:

Companies A-K

Jason Gerardi

Senior Manager, Business Development

Phone: 781-972-5452 Email: jgerardi@healthtech.com

 

Companies L-Z

Ashley Parsons

Manager, Business Development

Phone: 781-972-1340 Email: ashleyparsons@healthtech.com